Movement Disorders (revue) - Checkpoint (PascalFrancis)

Index « FC03.fr.i » - entrée « Mécanisme action »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Mécanisme < Mécanisme action < Médecin  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 34.
[0-20] [0 - 20][0 - 34][20-33][20-40]
Ident.Authors (with country if any)Title
001212 (2008) Constance Hammond [France] ; Rachida Amman [France] ; Bernard Bioulac [France] ; Liliana Garcia [France]Latest View on the Mechanism of Action of Deep Brain Stimulation
002292 (2003) Valérie Cochen [France] ; Maria-Joao Ribeiro [France] ; Jean-Paul Nguyen [France] ; Jean-Marc Gurruchaga [France] ; Gabriel Villafane [France] ; Christian Loc'H [France] ; Gilles Defer [France] ; Yves Samson [France] ; Marc Peschanski [France] ; Philippe Hantraye [France] ; Pierre Cesaro [France] ; Philippe Remy [France]Transplantation in Parkinson's disease: PET changes correlate with the amount of grafted tissue
002450 (2003) Juha-Matti Savola [Finlande] ; Michael Hill [Royaume-Uni] ; Mia Engstrom [Finlande] ; Hannele Merivuori [Finlande] ; Siegfried Wurster [Finlande] ; Steven G. Mcguire [Royaume-Uni] ; Susan H. Fox [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni]Fipamezole (JP-1730) is a potent α2 adrenergic receptor antagonist that reduces levodopa-induced dyskinesia in the MPTP-lesioned primate model of Parkinson's disease
002497 (2003) Ruediger Hilker [Allemagne] ; Juergen Voges [Allemagne] ; Mehran Ghaemi [Allemagne] ; Ralf Lehrke [Allemagne] ; Jobst Rudolf [Allemagne] ; Athanasios Koulousakis [Allemagne] ; Karl Herholz [Allemagne] ; Klaus Wienhard [Allemagne] ; Volker Sturm [Allemagne] ; Wolf-Dieter Heiss [Allemagne]Deep brain stimulation of the subthalamic nucleus does not increase the striatal dopamine concentration in Parkinsonian humans
002519 (2003) Frédéric Calon [Canada] ; Marc Morissette [Canada] ; Ali H. Rajput [Canada] ; Oleh Hornykiewicz [Canada, Autriche] ; Paul J. Bedard [Canada] ; Thérèse Di Paolo [Canada]Changes of GABA receptors and dopamine turnover in the postmortem brains of parkinsonians with levodopa-induced motor complications
002556 (2002) Ergun Y. Uc [États-Unis] ; Gerald A. Dienel [États-Unis] ; Nancy F. Cruz [États-Unis] ; Sami I. Harik [États-Unis]β-Adrenergics enhance brain extraction of levodopa
002694 (2002) Jonathan O. Dostrovsky [Canada] ; Andres M. Lozano [Canada]Mechanisms of deep brain stimulation
002695 (2002) Alim-Louis Benabid [France] ; Abdelhamid Benazzous [France] ; Pierre Pollak [France]Mechanisms of deep brain stimulation
002696 (2002) Jerrold L. Vitek [États-Unis]Mechanisms of deep brain stimulation: Excitation or inhibition
002911 (2001) Oum-Kaltoum Hassani [France] ; Mireille Mouroux [France] ; Georg Andrees Bohme [France] ; Jean-Marie Stutzmann [France] ; Jean Feger [France]Riluzole reduces hyperactivity of subthalamic neurons induced by unilateral 6-OHDA lesion in the rat brain
002931 (2001) Jon H. Falkenberg [États-Unis] ; Paul A. Laizzo [États-Unis] ; Linda K. Mcloon [États-Unis]Physiological assessment of muscle strength in vitro after direct injection of Doxorubicin into rabbit sternocleidomastoid muscle
002952 (2001) Susan H. Fox [Royaume-Uni] ; Brian Henry [Royaume-Uni] ; Micheal P. Hill [Royaume-Uni] ; David Peggs [Royaume-Uni] ; Alan R. Crossman [Royaume-Uni] ; Jonathan M. Brotchie [Royaume-Uni]Neural mechanisms underlying peak-dose dyskinesia induced by levodopa and apomorphine are distinct : Evidence from the effects of the Alpha2 adrenoceptor antagonist idazoxan
002966 (2001) Fabrizio Stocchi [Italie] ; Laura Vacca [Italie] ; Alfredo Berardelli [Italie] ; Francesca De Pandis [Italie] ; Stefano Ruggieri [Italie]Long-duration effect and the postsynaptic compartment : Study using a dopamine agonist with a short half-life
002A17 (2001) Y. R. Wu [Taïwan] ; R. Levy [Canada] ; P. Ashby [Canada] ; R. R. Tasker [Canada] ; J. O. Dostrovsky [Canada]Does stimulation of the GPi control dyskinesia by activating inhibitory axons?
002A36 (2001) Krishna P. Datla [Royaume-Uni] ; Stavia B. Blunt [Royaume-Uni] ; David T. Dexter [Royaume-Uni]Chronic L-DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6-OHDA or FeCl3 nigrostriatal lesions
002A76 (2000) Abstracts from International Conference 1999: Basic and Therapeutic Aspects of Botulinum and Tetanus Toxins, Orlando, FL, USA, November 16-18, 1999
002A96 (2000) Hasmet A. Hanagasi [Turquie] ; Gülüstü Kaptanoglu [Turquie] ; Hüseyin A. Sahin [Turquie] ; Murat Emre [Turquie]The use of NMDA antagonist memantine in drug-resistant dyskinesias resulting from L-dopa
002B46 (2000) Pieter Joost Van Wattum [États-Unis] ; Phillip B. Chappell [États-Unis] ; Daniel Zelterman [États-Unis] ; Lawrence D. Scahill [États-Unis] ; James F. Leckman [États-Unis]Patterns of response to acute naloxone infusion in Tourette's syndrome
002C10 (2000) Sarah A. Treseder [Royaume-Uni] ; Lance A. Smith [Royaume-Uni] ; Peter Jenner [Royaume-Uni]Endogenous dopaminergic tone and dopamine agonist action
002D09 (1999) S. Spieker [Allemagne] ; P.-A. Löschmann [Allemagne] ; T. Klockgether [Allemagne]The NMDA antagonist budipine can alleviate levodopa-induced motor fluctuations
002D87 (1999) D. Kunz [Allemagne] ; F. Bes [Allemagne]Melatonin as a therapy in REM sleep behavior disorder patients : An open-labeled pilot study on the possible influence of melatonin on REM-sleep regulation

List of associated Author.i

Nombre de
documents
Descripteur
2A. Cammarota
2Alan R. Crossman
2J. Balej
2Jonathan M. Brotchie
2M. Merello
2R. Leiguarda
2Susan H. Fox
1A. Feigin
1A. Gross
1A. R. Crossman
1A. T. Mcknight
1Abdelhamid Benazzous
1Alfredo Berardelli
1Ali H. Rajput
1Alim-Louis Benabid
1Andres M. Lozano
1Andrew Lees (neurologue)
1Athanasios Koulousakis
1Bernard Bioulac
1Brian Henry
1C. Lucetti
1Christian Loc'H
1Constance Hammond
1D. Kunz
1Daniel Zelterman
1David Peggs
1David T. Dexter
1Ergun Y. Uc
1F. Bes
1F. J. E. Stefano
1F. Ovsiew
1Fabrizio Stocchi
1Francesca De Pandis
1Frédéric Calon
1G. Dziewczapolski
1G. Gambaccini
1G. Herbster
1G. N. Woodruff
1Gabriel Villafane
1Georg Andrees Bohme
1Gerald A. Dienel
1Gilles Defer
1Gülüstü Kaptanoglu
1Hannele Merivuori
1Hasmet A. Hanagasi
1Hüseyin A. Sahin
1J. Castronuovo
1J. Gordon
1J. M. Brotchie
1J. M. Burns
1J. O. Dostrovsky
1J. P. Seibyl
1James F. Leckman
1Jean Feger
1Jean-Marc Gurruchaga
1Jean-Marie Stutzmann
1Jean-Paul Nguyen
1Jerrold L. Vitek
1Jobst Rudolf
1Jon H. Falkenberg
1Jonathan O. Dostrovsky
1Juergen Voges
1Juha-Matti Savola
1K. J. Meador
1K. L. Marek
1K. Sethi
1K. Sheff
1Karl Herholz
1Klaus Wienhard
1Krishna P. Datla
1L. B. Menalled
1Lance A. Smith
1Laura Vacca
1Lawrence D. Scahill
1Liliana Garcia
1Linda K. Mcloon
1M. B. H. Youdim
1M. Delfino
1M. Gassen
1M. Mora
1M. P. Hill
1M. T. Savino
1Marc Morissette
1Marc Peschanski
1Maria-Joao Ribeiro
1Mehran Ghaemi
1Mia Engstrom
1Michael Hill
1Micheal P. Hill
1Mireille Mouroux
1Murat Emre
1N. R. Hughes
1Nancy F. Cruz
1O. Betti
1O. Gershanik
1Oleh Hornykiewicz
1Oum-Kaltoum Hassani
1P. Ashby
1P. G. Wasielewski
1P. Piccini

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/FC03.fr.i -k "Mécanisme action" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/FC03.fr.i  \
                -Sk "Mécanisme action" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Checkpoint
   |type=    indexItem
   |index=    FC03.fr.i
   |clé=    Mécanisme action
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024